Zhenming Liu

机构：Shihezi University, King University, Zhejiang Chinese Medical University, Peking University, Fourth People’s Hospital of Jinan, BioMimetic Systems (United States), Drug Discovery Laboratory (Norway), Ministry of Industry and Information Technology, Xinjiang University · ORCID：0000-0002-8993-4015

发表论文 270 篇 · 总被引 6772 次 · h-index 39

代表论文

• The frameshifting element in coronaviruses: structure, function, and potential as a therapeutic target (2025 · Trends in Pharmacological Sciences · 被引 4)
• AI-Driven Discoveryand Optimization of Positive AllostericModulators for NMDA Receptors: Potential Applications in Depression (2025 · Journal of Medicinal Chemistry · 被引 3)
• Structure-BasedDiscovery of Quinazolin-2-amine Derivativesas Potent ROR1 Pseudokinase Inhibitors with In Vitro and In Vivo Efficacy against Triple-Negative BreastCancer (2025 · Journal of Medicinal Chemistry · 被引 3)
• Discovery of novel PI3KC2γ inhibitors with high potency, selectivity, and favorable pharmacokinetics for glycogen metabolism regulation (2025 · European Journal of Medicinal Chemistry · 被引 3)
• Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic Activity (2025 · Journal of Medicinal Chemistry · 被引 3)
• ExplainingIsoform Selectivity of c-Jun N-TerminalKinase 3 (JNK3) Inhibitors through Its Development and StructuralInsights (2025 · Journal of Medicinal Chemistry · 被引 2)